Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells
Back to article page
OriginalPaper|Updated:2021-08-27
|
Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells
Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells
中国结合医学杂志(英文版)2012年18卷第3期 页码:197-202
Affiliations:
Department of Traditional Chinese Medicine, Changhai Hospital, Second Military Medical University,Shanghai,China
Author bio:
Funds:
Supported by the National Natural Science Foundation of China (No. C0305020), the Traditional Chinese Medicine Modernization Project of Science and Technology Commission of Shanghai Municipality (No. 04DZ19808), and the Open Project Foundation of Key Laboratory of Liver and Kidney Diseases (Shanghai University of Traditional Chinese Medicine), Ministry of Education
Zheng, Gy., Xin, Hl., Li, B. et al. Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells., Chin. J. Integr. Med. 18, 197–202 (2012). https://doi.org/10.1007/s11655-012-1055-5
Guo-yin Zheng, Hai-liang Xin, Bai Li, et al. Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells[J]. Chinese Journal of Integrative Medicine, 2012,18(3):197-202.
Zheng, Gy., Xin, Hl., Li, B. et al. Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells., Chin. J. Integr. Med. 18, 197–202 (2012). https://doi.org/10.1007/s11655-012-1055-5DOI:
Guo-yin Zheng, Hai-liang Xin, Bai Li, et al. Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells[J]. Chinese Journal of Integrative Medicine, 2012,18(3):197-202. DOI: 10.1007/s11655-012-1055-5.
Total saponin from root of Actinidia Valvata Dunn prevents the metastasis of human hepatocellular carcinoma cells
摘要
To extract the active component from the root of Actinidia valvata Dunn and to investigate the effects on hepatocellular carcinoma (HCC) cells in vitro. Total saponin was extracted from the root of A. valvata (TSAVD). HCC cells
such as BEL-7402
HepG2
PLC
SMMC-7721
MHCC-97-H
and MHCC-97-L
were treated with TSAVD in 3-(4
5-Dimethylthiazol-2-yl)-2
5-diphenytetrazolium bromide (MTT) assay. BEL-7402 and MHCC-97-H cells were also treated respectively with TSAVD at different concentrations for 24 h in wound healing and adhesion assays
and the effects of TSAVD on BEL-7402 and MHCC-97-H cells mobility and adhesion abilities were observed. Meanwhile
the effects of TSAVD on invasion and migration of BEL-7402 and MHCC-97-H cells were also investigated by transwell chamber in invasion and migration assays. TSAVD at 1.5 mg/mL inhibited BEL-7402 cell proliferation with inhibition ratios (IRs) of 61.08%
74.12%
84.55% at 24
48
and 72 h
respectively. Meanwhile
TSAVD inhibited MHCC-97-H proliferation in a concentration-dependent manner from 1.5 to 0.5 mg/mL
with the IR of 36% at 1.5 mg/mL at 24 h. For SMMC-7721
PLC
and HepG2
the IR was lower than 30% at 1.5 mg/mL at 24 h. In the wound healing assay
mobility abilities of BEL-7402 and MHCC-97-H cells in TSAVD treated groups were significantly weaker than those of the control group. After pretreatment for 24 h with TSAVD
adhesion abilities were reduced in both MHCC-97-H and BEL-7402 cells
with IRs of 48.50%±4.86% and 49.85%±5.25% at 200 μg/mL. The IRs of MHCC-97-H and BEL-7402 cells in the migration assay were 49.13%±2.91% and 79.37%±0.09% at 200 μg/mL. In the invasion assay
IRs were 69.78%±4.88% and 82.48%±0.25% at 200 μg/mL. Of all HCC cells
the highest inhibition by TSAVD was seen for BEL-7402 proliferation. TSAVD could restrain adhesion
invasion
mobility
and migration abilities of BEL-7402 and MHCC-97-H cells in vitro.
Abstract
To extract the active component from the root of Actinidia valvata Dunn and to investigate the effects on hepatocellular carcinoma (HCC) cells in vitro. Total saponin was extracted from the root of A. valvata (TSAVD). HCC cells
such as BEL-7402
HepG2
PLC
SMMC-7721
MHCC-97-H
and MHCC-97-L
were treated with TSAVD in 3-(4
5-Dimethylthiazol-2-yl)-2
5-diphenytetrazolium bromide (MTT) assay. BEL-7402 and MHCC-97-H cells were also treated respectively with TSAVD at different concentrations for 24 h in wound healing and adhesion assays
and the effects of TSAVD on BEL-7402 and MHCC-97-H cells mobility and adhesion abilities were observed. Meanwhile
the effects of TSAVD on invasion and migration of BEL-7402 and MHCC-97-H cells were also investigated by transwell chamber in invasion and migration assays. TSAVD at 1.5 mg/mL inhibited BEL-7402 cell proliferation with inhibition ratios (IRs) of 61.08%
74.12%
84.55% at 24
48
and 72 h
respectively. Meanwhile
TSAVD inhibited MHCC-97-H proliferation in a concentration-dependent manner from 1.5 to 0.5 mg/mL
with the IR of 36% at 1.5 mg/mL at 24 h. For SMMC-7721
PLC
and HepG2
the IR was lower than 30% at 1.5 mg/mL at 24 h. In the wound healing assay
mobility abilities of BEL-7402 and MHCC-97-H cells in TSAVD treated groups were significantly weaker than those of the control group. After pretreatment for 24 h with TSAVD
adhesion abilities were reduced in both MHCC-97-H and BEL-7402 cells
with IRs of 48.50%±4.86% and 49.85%±5.25% at 200 μg/mL. The IRs of MHCC-97-H and BEL-7402 cells in the migration assay were 49.13%±2.91% and 79.37%±0.09% at 200 μg/mL. In the invasion assay
IRs were 69.78%±4.88% and 82.48%±0.25% at 200 μg/mL. Of all HCC cells
the highest inhibition by TSAVD was seen for BEL-7402 proliferation. TSAVD could restrain adhesion
invasion
mobility
and migration abilities of BEL-7402 and MHCC-97-H cells in vitro.
Wu T. Cyclooxygenase-2 in hepatocellular carcinoma. Cancer Treat Rev 2006;32(1):28–44.
Wu MC. Traditional Chinese medicine in prevention and treatment of liver cancer: function, status and existed problems. J Chin Integr Med (Chin) 2003;1:163–164.
Ling CQ. Problems in cancer treatment and major research of integrative medicine. J Chin Integr Med (Chin) 2003;1:168–170.
Zhang YN, Lu L, Ling CQ. Inhibition effect of active fraction from Actinidia valvata on growth of transplanted mouse tumor cells and preliminary study of its mechanism. China J Chin Mater Med (Chin) 2006;31:918–920.
Lu Y, Chen SY, Wu P, Chan G, Fu CX. Studies on the effective components of Actinidia macrosperma (Actinidiaceae) (I)-Analysis on the inorganic elements. J Zhejiang Univ (Agric Life Sci, Chin) 2004;30:185–188.
Feng YT. Chen SY, Jiang WM, Fu CX. Study on the effective components of Actinidia macrosperma (II)-Analysis on the amino acids, J Zhejiang Univ (Agric Life Sci, Chin) 2004;30:189–190.
Liu S, Yu M, He Y, Xiao L, Wang F, Song C, et al. Melittin prevents liver cancer cell metastasis through inhibition of Rac1-dependent pathway. Hepatology 2008;47:1964–1973.
Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, et al. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. J Cancer Res Clin 2003;129:43–51.
Steeg PS. Metastasis suppressors alter the signal transduction of cancer cells. Nat Rev Cancer 2003;3:55–63.
Preventive effects of Jiedu Granules (解毒颗粒) combined with Cinobufacini Injection (华蟾素注射液) versus transcatheter arterial chemoembolization in post-surgical patients with hepatocellular carcinoma: A case-control trial
Nodule and eminence on frenulum labii superioris: Diagnostic markers for metastatic colorectal cancer
Bear bile powder (熊胆粉) induces apoptosis of human hepatocellular carcinoma cells via mitochondrion-dependent pathway
Identifying the targets for treatment of liver fibrosis and hepatocellular carcinoma from both Western medicine and Chinese medicine
Oxysophoridine suppresses the growth of hepatocellular carcinoma in mice: In Vivo and cDNA microarray studies
相关作者
暂无数据
相关机构
Tianjin Medical University
National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital
Fujian Guizhentang Pharmaceutical Co., Ltd.
Fujian Key Laboratory of Integrative Medicine on Geriatrics, Fujian University of Traditional Chinese Medicine